Addition of Renowned Scientist Underscores Commitment to Vibrant and Innovative Scientific Research WESTON, Mass.--(BUSINESS WIRE)-- Biogen Idec... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=4624&title=Biogen-Idec-Appoints-Spyros-ArtavanisTsakonas-Chief-Scientific-OfficerJune 19-20, 2013 New York Academy of Sciences, New York, NY - Host-Targeted Antiviral Validated to Block Patient-Derived JC Virus - PR Newswire... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=46332&title=Inhibikase-Therapeutics-to-present-at-Industry-Conference-on-DrugInduced-Progressive-Multifocal-Leukoencephalopathy-PMLDUBLIN/ WASHINGTON Ireland-based biotechnology firm Elan Thursday rejected Royalty Pharma's increased $6.4 billion takeover bid, shortly after the... ...
http://www.mumbainews.net/index.php/sid/214724870/scat/3a8a80d6f705f8ccBiogen Idec (BIIB) recently submitted a Biologics License Application (BLA) in the US for its multiple sclerosis candidate, Plegridy (peginterferon... ...
http://in.quote.com/news/zacksCache.aspx?id=709544(GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today the appointment of two additional members to Vical's Board of Directors:... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=311109